Liberante, F. G., Pouryahya, T., McMullin, M., Zhang, S., & Mills, K. I. (2015). Identification and validation of the dopamine agonist bromocriptine as a novel therapy for high-risk myelodysplastic syndromes and secondary acute myeloid leukemia. Oncotarget.

Liberante, Fabio Giuseppe, Tara Pouryahya, Mary-Frances McMullin, Shu-Dong Zhang, a Kenneth Ian Mills. "Identification and Validation of the Dopamine Agonist Bromocriptine As a Novel Therapy for High-risk Myelodysplastic Syndromes and Secondary Acute Myeloid Leukemia." Oncotarget 2015.

Liberante, Fabio Giuseppe, et al. "Identification and Validation of the Dopamine Agonist Bromocriptine As a Novel Therapy for High-risk Myelodysplastic Syndromes and Secondary Acute Myeloid Leukemia." Oncotarget 2015.